Why Cancer cases are rising worldwide | Explained
Global Status Report on Cancer 2026: Cancer disparities — availability of the top 20 priority cancer medicines ranges from just 9% to 54% in low- and lower-middle-income countries, compared with 68% to 94% in high-income countries
This is a preview. The full story is available on The Hindu.
Read Full Article on The Hindu